-
Product Insights
Hypothyroidism – Drugs In Development, 2023
Global Markets Direct’s, ‘Hypothyroidism - Drugs In Development, 2023’, provides an overview of the Hypothyroidism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypothyroidism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Thyroid Gland Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Thyroid Gland Disorders - Drugs In Development, 2023’, provides an overview of the Thyroid Gland Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thyroid Gland Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Company Profile
Synthon International Holdings BV – Company Profile
Synthon International Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture, and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. It’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out...
Add to Basket -
Product Insights
Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease. The Hypothyroidism pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Hypothyroidism, complete with analysis by stage of development, drug target, mechanism...
-
Product Insights
Parkinson’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists. The Parkinson’s disease pipeline drugs market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Phobia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2018" provides an overview of Phobia clinical trials scenario. This report provides top line data relating to the clinical trials on Phobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Fungemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2017" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcal Meningitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcal Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cryptococcosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H2, 2017" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hormone Sensitive Breast Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Hormone Sensitive Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Sensitive Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...